| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药工业(元) | 206,029,677.29 | 539,572,809.03 | 285,847,304.46 | 671,920,777.02 | 368,802,713.02 |
| 医药商业(元) | 665,786,728.43 | 1,736,038,340.17 | 997,419,822.47 | 3,068,767,693.17 | 1,590,040,236.86 |
| 营业成本(元) | |||||
| 医药工业(元) | 151,040,776.17 | 300,782,144.07 | 134,941,359.82 | 362,026,147.03 | 205,270,727.04 |
| 医药商业(元) | 521,623,862.60 | 1,407,351,998.88 | 822,150,923.34 | 2,674,981,591.06 | 1,376,675,488.01 |
| 毛利(元) | |||||
| 医药工业(元) | 54,988,901.12 | 238,790,664.96 | 150,905,944.64 | 309,894,629.99 | 163,531,985.98 |
| 医药商业(元) | 144,162,865.83 | 328,686,341.29 | 175,268,899.13 | 393,786,102.11 | 213,364,748.85 |
| 毛利率(%) | |||||
| 医药工业(%) | 26.69 | 44.26 | 52.79 | 46.12 | 44.34 |
| 医药商业(%) | 21.65 | 18.93 | 17.57 | 12.83 | 13.42 |
| 收入构成(%) | |||||
| 医药工业(%) | 23.63 | 23.71 | 22.27 | 17.96 | 18.83 |
| 医药商业(%) | 76.37 | 76.29 | 77.73 | 82.04 | 81.17 |
| 毛利构成(%) | |||||
| 医药工业(%) | 27.61 | 42.08 | 46.27 | 44.04 | 43.39 |
| 医药商业(%) | 72.39 | 57.92 | 53.73 | 55.96 | 56.61 |